Nasus Pharma Ltd (NSRX): Koefisien rega marang pendapatan

The estimated P/S displayed by the GURU.Markets portal shows a current value of 0.00, which correlates with the strong pricing power of Nasus Pharma Ltd (NSRX) within the emergency medicine segment. Nasus Pharma Ltd (NSRX) is developing a network of Asian distributors to expand its sales reach. The business model relies on the creation of innovative nasal sprays and barrier agents for the rapid delivery of medications through the nasal mucosa.

Rasio rega marang pendapatan: Nasus Pharma, Ltd. (NSRX) kanggo 14.08.2025 - 16.08.2025

Rincian metrik lan analitis perusahaan nasuspharma.com (NSRX)

- nilai saham lan prakiraan konsensus rega:

Rega saham Nasus Pharma Ltd.|NSRX - Bagan rega target

- data kapitalisasi bursa:

Kapitalisasi pasar Nasus Pharma Ltd|NSRX - Rega Nyata Tumbas Perusahaan Kanthi Wutuh

- rincian nilai buku perusahaan:

Nilai Buku saben Saham Nasus Pharma|NSRX - Nilai Buku Perusahaan|Kapitalisasi Pasar marang Nilai Buku nasuspharma.com|NSRX - Gunggung Aset Perusahaan

- rincian struktur utang lan likuiditas bisnis:

Rasio Kabeh Utang marang Dana Pribadi Nasus Pharma Ltd|NSRX - Utang jangka dawa marang ekuitas|Kewajiban jangka cendhak marang ekuitas Nasus Pharma|NSRX - Gunggung utang perusahaan|Rasio utang marang aset resik Nasus Pharma Ltd|NSRX - Utang jangka dawa perusahaan|Utang jangka cendhak perusahaan Nasus Pharma|Rasio jangkoan perantara nasuspharma.com

- indikator profitabilitas perusahaan lan kelipatan valuasi:

NSRX - Bathi resik perusahaan|Bathi mangsa ngarep Nasus Pharma Ltd|NSRX - Pangali P/E|Pangali Forward P/E Nasus Pharma, Ltd.|NSRX - Pangali rega marang bathi tumrap wutah|Nilai bisnis marang bathi operasional sadurunge panyusutan Nasus Pharma|NSRX - Bathi sadurunge mbayar bunga, pajak, lan amortisasi|Bathi saben saham sajrone rolas wulan pungkasan Nasus Pharma|NSRX - Bathi resik saben saham sajrone 12 wulan pungkasan|Kacepetan wutah bathi saben saham taun-ka-taun sajrone rolas wulan pungkasan nasuspharma.com|NSRX - Wutah bathi ing taun lumaku|Proyeksi kacepetan wutah bathi saben saham kanggo taun ngarep Nasus Pharma Ltd

- data total pendapatan lan volume dodolan:

NSRX - Pendapatan perusahaan|Prakiraan pendapatan perusahaan Nasus Pharma Ltd.|NSRX - Rasio rega marang pendapatan|Rasio kapitalisasi marang dodolan sing dikarepake Nasus Pharma|NSRX - Wutah dodolan YoY sajrone rolas wulan kepungkur

Analisis umum perusahaan:Nasus Pharma, Ltd., NSRX

Analyzing the scale of operations at Nasus Pharma Ltd (NSRX) requires comparing the business's market value to its operating revenues via the price-to-sales ratio. This metric determines how many dollars of capitalization are attributed to each dollar of sales, revealing whether the asset is overvalued. The calculation mechanics correlate the total equity value with annual turnover, warning of the risks of buying at the peak. Stable demand for nasal inhalers makes this indicator key to assessing the sustainability of cash flows.

Perusahaan pesaing